Showing 1-3 of about 3 articles.
Genelux Corporation
First two patients dosed in Phase 1b Trial in Ovarian Cancer at Florida Hospital Cancer Institute (FHCI) First three patients dosed in Phase 1b Trial in Solid Organ Cancers at Moores Cancer Center at...
Genelux Corporation
Data Demonstrate Favorable Safety Profile and Anti-Tumor Activity
Results to be Presented at ASCO Annual Meeting 2015 During Two Poster Presentations
SAN DIEGO, May 27, 2015 (GLOBE NEWSWIRE) --...
Genelux Corporation
SAN DIEGO, May 12, 2015 (GLOBE NEWSWIRE) -- Genelux Corporation, a clinical-stage biopharmaceutical company focused on the development of vaccinia virus for oncolytic immunotherapy, today announced...
Showing 1-3 of about 3 articles.
